Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: The JenaValve ALIGN-AR LVAD Registry [NA]

View source ↗

Summary

The JenaValve ALIGN-AR LVAD Registry is currently recruiting, focusing on patients with aortic regurgitation and related left ventricular dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: JenaValve Technology, Inc. | Conditions: Aortic Regurgitation, Aortic Valve Insufficiency | NA | Status: RECRUITING